Regeneron Pharmaceuticals... (REGN)
NASDAQ: REGN
· Real-Time Price · USD
571.51
5.54 (0.98%)
At close: Aug 15, 2025, 12:30 PM
Regeneron Pharmaceuticals Revenue
Regeneron Pharmaceuticals reported an annual revenue of $14.2B, reflecting a 8.27% growth. For the quarter ending June 30, 2025, Regeneron Pharmaceuticals generated $3.68B in revenue.
Revenue (ttm)
14.2B
Revenue Growth
8.27%
Price / Sales Ratio
5.41
Revenue / Employee
936.93K
Employees
15,158
Market Cap
59.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|